🔴 Aspire BioPharma is trading 5.83% down today — no clear company-specific catalyst identified

Aspire BioPharma is trading 5.83% down now at $8.34 after no clear company-specific catalyst was identified for the September 9, 2026 decline.

• The company announced a $10 million share-repurchase authorization on September 9, while a corporate name change was reported on September 8; neither directly explains the drop.
• Broader markets were modestly lower, but evidence is insufficient to attribute the movement to global sentiment.